We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+18.24%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30B
AUM Growth
+$2.64B
(+9.6%)
Cap. Flow
+$10.9B
Cap. Flow
% of AUM
36.32%
Top 10 Holdings %
Top 10 Hldgs %
9.49%
Holding
835
New
69
Increased
208
Reduced
338
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$13B |
| 2 |
Citigroup
C
|
+$151M |
| 3 |
AXIS Capital
AXS
|
+$135M |
| 4 |
RTX Corp
RTX
|
+$123M |
| 5 |
Edison International
EIX
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$146M |
| 2 |
Cisco
CSCO
|
+$112M |
| 3 |
Honeywell
HON
|
+$97.8M |
| 4 |
UnitedHealth
UNH
|
+$92.6M |
| 5 |
Citizens Financial Group
CFG
|
+$86.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.12% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 13.47% |
| 4 | Industrials | 11.75% |
| 5 | Consumer Discretionary | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCS
551
DELISTED
Steelcase
SCS
| $7.58M | 0.03% |
+520,832
| New | +$8.66M |
|
552
TSMC
TSM
$1.94T
| $7.57M | 0.03% |
184,915
+61,600
| +50% | +$2.35M |
|
553
Itaú Unibanco
ITUB
$89.8B
| $7.55M | 0.03% |
1,177,136
-144,777
| -11% | -$1.02M |
|
554
AppFolio
APPF
$6.62B
| $7.52M | 0.03% |
94,757
-2,287
| -2% | -$153K |
|
555
Vail Resorts
MTN
$5.7B
| $7.49M | 0.02% |
34,469
+884
| +3% | +$181K |
|
556
Veeva Systems
VEEV
$33.8B
| $7.49M | 0.02% |
+59,000
| New | +$6.65M |
|
557
OrthoPediatrics
KIDS
$513M
| $7.47M | 0.02% |
+168,963
| New | +$6.43M |
|
558
TriMas Corp
TRS
$1.41B
| $7.29M | 0.02% |
241,245
-5,563
| -2% | -$165K |
|
|
VAPO
559
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $7.29M | 0.02% |
46,373
-1,076
| -2% | -$154K |
|
|
RARX
560
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $7.23M | 0.02% |
+322,785
| New | +$6.94M |
|
|
DCPH
561
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.15M | 0.02% |
308,132
+71,525
| +30% | +$1.87M |
|
562
Emergent Biosolutions
EBS
$379M
| $7.04M | 0.02% |
139,420
-166,831
| -54% | -$9.84M |
|
|
NOAH
563
Noah Holdings
NOAH
$590M
| $7.04M | 0.02% |
+145,275
| New | +$7.05M |
|
564
8x8 Inc
EGHT
$279M
| $7.03M | 0.02% |
347,905
-135,700
| -28% | -$2.65M |
|
565
Upwork
UPWK
$1.18B
| $6.94M | 0.02% |
362,702
-354,828
| -49% | -$7.27M |
|
566
SLM Corp
SLM
$4.83B
| $6.93M | 0.02% |
698,975
+17,335
| +3% | +$179K |
|
|
DCUD
567
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $6.9M | 0.02% |
138,216
-1,235
| -0.9% | -$60.1K |
|
568
Trimble
TRMB
$13.6B
| $6.83M | 0.02% |
168,990
+4,219
| +3% | +$160K |
|
|
EIDX
569
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $6.76M | 0.02% |
+288,222
| New | +$4.62M |
|
570
Haemonetics
HAE
$3.88B
| $6.72M | 0.02% |
76,862
-126,296
| -62% | -$11.5M |
|
571
DXC Technology
DXC
$1.91B
| $6.63M | 0.02% |
103,101
+2,650
| +3% | +$169K |
|
572
Victory Capital Holdings
VCTR
$6.09B
| $6.48M | 0.02% |
431,292
+290,184
| +206% | +$3.54M |
|
573
Boston Scientific
BSX
$68.4B
| $6.44M | 0.02% |
167,799
-710,908
| -81% | -$27.2M |
|
574
American Financial Group
AFG
$11.9B
| $6.42M | 0.02% |
+66,700
| New | +$6.39M |
|
575
Neuronetics
STIM
$127M
| $6.38M | 0.02% |
418,416
-9,591
| -2% | -$159K |
|
Similar funds
Lord, Abbett & Co's Q1 2019 Portfolio in Review
As of Q1 2019, Lord, Abbett & Co held 835 positions worth $30B, up 9.6% from $27.4B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
Lord, Abbett & Co deployed $10.9B of net new capital in Q1 2019, opening 69 new positions and adding to 208 existing holdings. Its largest new stake was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 12,559,121 shares worth $69.1M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Microsoft, an estimated $146M trimmed.
- Lord, Abbett & Co's largest Q1 2019 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 12,559,121 shares worth $69.1M.
- Lord, Abbett & Co added most to Citigroup in Q1 2019, an estimated $151M increase.
- Lord, Abbett & Co's biggest Q1 2019 reduction was Microsoft, cutting an estimated $146M.
- Lord, Abbett & Co fully exited UnitedHealth in Q1 2019, selling an estimated $92.6M.
- Lord, Abbett & Co's ten largest holdings make up 9.5% of its $30B portfolio in Q1 2019.
- Lord, Abbett & Co opened 69 new positions and closed 135 in Q1 2019.
- Lord, Abbett & Co's portfolio value rose 9.6% quarter-over-quarter to $30B.
Based on Lord, Abbett & Co's 13F filing for Q1 2019, filed 15 May 2019.